Sagimet Biosciences Shares Are Trading Higher After HC Wainwright & Co. Initiated Coverage on the Stock With a Buy Rating and Announced a $32 Price Target
继HC Wainwright & Co之后,Sagimet Biosciences的股价走高以买入评级开始对该股进行报道,并宣布了32美元的目标股价
Sagimet Biosciences Shares Are Trading Higher After HC Wainwright & Co. Initiated Coverage on the Stock With a Buy Rating and Announced a $32 Price Target
继HC Wainwright & Co之后,Sagimet Biosciences的股价走高以买入评级开始对该股进行报道,并宣布了32美元的目标股价
使用浏览器的分享功能,分享给你的好友吧